Yahoo Finance • 3 days ago
WALTHAM, Mass. and BOULDER, Colo., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced that on Se... Full story
Yahoo Finance • 2 months ago
[Close up of buildings in Wall Street] Alphotographic Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may impact stock prices next week. MON... Full story
Yahoo Finance • 3 months ago
Cogent Biosciences Inc. stock has reached a new 52-week high, hitting a price of 12.66 USD. According to InvestingPro data, the stock has shown remarkable momentum with a 51.9% gain over the past six months and currently trades at 12.75 US... Full story
Yahoo Finance • 3 months ago
Investing.com - Citi has raised its price target on Cogent (NASDAQ:COGT) to $22.00 from $15.00 while maintaining a Buy rating, citing positive results from the company’s SUMMIT trial. The new target sits well within the analyst range of $9... Full story
Yahoo Finance • 3 months ago
Cogent Biosciences, Inc. (NASDAQ:COGT) is one of the 10 Best Small-Cap Stocks to Buy According to Billionaires. On July 7, Jefferies increased its price target on Cogent Biosciences, Inc. (NASDAQ:COGT) from $23 to $28 and reiterated a “Buy... Full story
Yahoo Finance • 3 months ago
WALTHAM, Mass. and BOULDER, Colo., July 10, 2025 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced the closing... Full story
Yahoo Finance • 3 months ago
WALTHAM, Mass. and BOULDER, Colo., July 08, 2025 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced the pricing... Full story
Yahoo Finance • 3 months ago
WALTHAM, Mass. and BOULDER, Colo., July 08, 2025 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced that it has... Full story
Yahoo Finance • 3 months ago
Monday’s trading session is showcasing significant movements across various market cap categories. Mega-cap giants like Tesla Motors (NASDAQ:TSLA) and Palantir Technologies Inc (NASDAQ:PLTR) have experienced notable shifts, while large... Full story
Yahoo Finance • 3 months ago
[Financial bar graph on futuristic digital landscape with glowing data] AlexSecret Cogent Biosciences (NASDAQ:COGT [https://seekingalpha.com/symbol/COGT]) surged ~31% Monday after releasing positive mid-stage data on bezuclastinib, its ca... Full story
Yahoo Finance • 3 months ago
Investing.com -- Cogent Biosciences, Inc. (NASDAQ:COGT) stock surged 10% after announcing positive top-line results from its SUMMIT trial of bezuclastinib in patients with non-advanced systemic mastocytosis (NonAdvSM). The company reporte... Full story
Yahoo Finance • 3 months ago
-- Patients treated with bezuclastinib showed a superior mean change in total symptom score at 24 weeks (-24.3 points vs. -15.4 points, -8.91 point placebo-adjusted difference; p=0.0002), compared to patients treated with placebo, establis... Full story
Yahoo Finance • 4 months ago
Piper Sandler reiterated its Overweight rating and $24.00 price target on Cogent Biosciences (NASDAQ:COGT) Monday as the company approaches a crucial data readout for its drug bezuclastinib. Currently trading at $7.03, the stock sits well... Full story
Yahoo Finance • 4 months ago
(RTTNews) - On Wednesday, Cogent Biosciences, Inc. (COGT), a biotechnology company, announced it has secured a debt financing facility of up to $400 million from credit funds managed by SLR Capital Partners, LLC. An initial $50 million wa... Full story
Yahoo Finance • 5 months ago
We recently published a list of Top 11 Small Cap Stocks to Buy with Biggest Upside Potential. In this article, we are going to take a look at where Cogent Biosciences, Inc. (NASDAQ:COGT) stands against other top small cap stocks to buy wit... Full story
Yahoo Finance • 6 months ago
We recently published a list of the 13 Best Biotech Penny Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Cogent Biosciences Inc. (NASDAQ:COGT) stands against other biotech penny stocks. Peter... Full story
Yahoo Finance • 6 months ago
WALTHAM, Mass. and BOULDER, Colo., March 25, 2025 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced four precl... Full story
Yahoo Finance • 8 months ago
WALTHAM, Mass. and BOULDER, Colo., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced an upcoming... Full story
Yahoo Finance • 2 years ago
In this article, we will take a look at the 15 small-cap stocks with high potential. To skip our analysis of the latest trends, and market activity, you can go directly to see the 5 Small-Cap Stocks with High Potential. Nearly 9,500 stock... Full story
Yahoo Finance • 2 years ago
WALTHAM, Mass. and BOULDER, Colo., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced two poster... Full story